Edwards Lifesciences Corp (EW) stock news · P/E 50, rev $6.07B
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
This EW news page leads with what Edwards Lifesciences Corp filed — not a scraped headline mill.
No cached 8-K sentence for EW yet. We will not pad this page with generic market recap.
Latest reported EW revenue for 2025-12-31 was $6.07B. Net income was $1.07B. Revenue was up 1.0% from 2023-12-31 to 2025-12-31. EW currently screens at market cap $49.91B and trailing P/E 50.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the EW stock page; for the tape open the quote page.
EW stock news FAQ
What are EW's latest revenue and net income?
Latest cached Edwards Lifesciences Corp (EW) revenue for Dec 31, 2025 was $6.07B. Net income was $1.07B. Statements: https://lician.com/financials/ew
How did EW revenue change from the prior cached period?
Cached Edwards Lifesciences Corp (EW) revenue was up 1.0% from $6.00B (Dec 31, 2023) to $6.07B (Dec 31, 2025). Statements: https://lician.com/financials/ew
What is EW's P/E ratio?
Edwards Lifesciences Corp (EW) trailing P/E is 50.3 on the latest cached fundamentals snapshot.
What is EW's market cap?
Edwards Lifesciences Corp (EW) market cap is $49.91B on the latest cached fundamentals snapshot.
What kind of company is EW?
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Where is EW stock news listed?
Cached stock news for Edwards Lifesciences Corp (EW) is listed at https://lician.com/news/ew. Filings: https://lician.com/sec/ew
Not investment advice.